Cited by 870Schizophrenia research and treatmentMental Health Treatment and AccessPsychiatric care and mental health services

The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level

Open access

DE HERT, MARC, COHEN, DAN, BOBES, JULIO, CETKOVICH‐BAKMAS, MARCELO, LEUCHT, STEFAN, NDETEI, DAVID M., NEWCOMER, JOHN W., UWAKWE, RICHARD, ASAI, ITSUO, MÖLLER, HANS‐JURGEN, GAUTAM, SHIV, DETRAUX, JOHAN, CORRELL, CHRISTOPH U.·2011·World Psychiatry

DOI 10.1002/j.2051-5545.2011.tb00036.xPMC PMC3104888

Open this paper in CoChat — free account Open PDF

Abstract

Physical disorders are, compared to the general population, more prevalent in people with severe mental illness (SMI). Although this excess morbidity and mortality is largely due to modifiable lifestyle risk factors, the screening and assessment of physical health aspects remains poor, even in developed countries. Moreover, specific patient, provider, treatment and system factors act as barriers to the recognition and to the management of physical diseases in people with SMI. Psychiatrists can play a pivotal role in the improvement of the physical health of these patients by expanding their task from clinical psychiatric care to the monitoring and treatment of crucial physical parameters. At a system level, actions are not easy to realize, especially for developing countries. However, at an individual level, even simple and very basic monitoring and treatment actions, undertaken by the treating clinician, can already improve the problem of suboptimal medical care in this population. Adhering to monitoring and treatment guidelines will result in a substantial enhancement of physical health outcomes. Furthermore, psychiatrists can help educate and motivate people with SMI to address their suboptimal lifestyle, including smoking, unhealthy diet and lack of exercise. The adoption of the recommendations presented in this paper across health care systems throughout the world will contribute to a significant improvement in the medical and related psychiatric health outcomes of patients with SMI.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/j.2051-5545.2011.tb00036.x

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,379
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults
DONNELLY, J. E., BLAIR, S. N., JAKICIC, J. M., MANORE, M. M., RANKIN, J. W., & SMITH, B. K. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181949333 · Cited by 2,658
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Self-citation
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975
Untitled work
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554
2008 Physical activity guidelines for Americans
(2008) · PsycEXTRA Dataset · doi:10.1037/e525412010-001 · Cited by 1,473
Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.
(2006) · Europe PMC (PubMed Central) · Cited by 1,299
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., LAUGHREN, T. P., & Katz, R. G. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
Barriers to improvement of mental health services in low-income and middle-income countries
Saraceno, B., van Ommeren, M., Batniji, R., Cohen, A., Gureje, O., Mahoney, J., Sridhar, D., & Underhill, C. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61263-x · Cited by 1,088
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Self-stigma and the “why try” effect: impact on life goals and evidence-based practices
CORRIGAN, P. W., LARSON, J. E., & RÜSCH, N. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00218.x · Cited by 1,074
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050
Self-citation
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951
Self-citation
The unhealthy lifestyle of people with schizophrenia
Brown, S., Birtwistle, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 880
A New International Diabetes Federation (IDF) Worldwide Definition of the Metabolic Syndrome: the Rationale and the Results
Zimmet, P., Alberti, K. G. M. M., & Serrano Ríos, M. (2005) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60742-1 · Cited by 864
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P. B., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
Physical Health Monitoring of Patients With Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N. H., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1334 · Cited by 812
Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease
Bassuk, S. S., & Manson, J. E. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00160.2005 · Cited by 744
Review: Inequalities in healthcare provision for people with severe mental illness
Lawrence, D., & Kisely, S. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382058 · Cited by 649
Metabolic syndrome in people with schizophrenia: a review
DE HERT, M., SCHREURS, V., VANCAMPFORT, D., & VAN WINKEL, R. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00199.x · Cited by 634
Medical Comorbidity in Schizophrenia
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., & Lacro, J. P. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.413 · Cited by 617
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline
Nasrallah, H. A., Meyer, J. M., GOFF, D. C., McEvoy, J. P., Thomas, S., Stroup, T. S., & Lieberman, J. A. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.06.026 · Cited by 563
Diet, smoking and cardiovascular risk in people with schizophrenia
McCreadie, R. G., & Scottish Schizophrenia Lifestyle Group (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.6.534 · Cited by 559
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Quality of Medical Care and Excess Mortality in Older Patients With Mental Disorders
Druss, B. G., Bradford, W. D., Rosenheck, R. A., Radford, M. J., & Krumholz, H. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.565 · Cited by 490
A Randomized Trial of Medical Care Management for Community Mental Health Settings: The Primary Care Access, Referral, and Evaluation (PCARE) Study
Druss, B. G., von Esenwein, S. A., Compton, M. T., Rask, K. J., Zhao, L., & Parker, R. M. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09050691 · Cited by 415
Serious mental illness and physical health problems: A discussion paper
Robson, D., & Gray, R. (2007) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2006.07.013 · Cited by 411
Endocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and Adolescents
Correll, C. U., & Carlson, H. E. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000220851.94392.30 · Cited by 406
Self-citation
Obesity Among Those with Mental Disorders
Allison, D. B., Newcomer, J. W., Dunn, A. L., Blumenthal, J. A., Fabricatore, A. N., Daumit, G. L., Cope, M. B., Riley, W. T., Vreeland, B., Hibbeln, J. R., et al. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.11.020 · Cited by 403
Self-citation
The Primary Prevention of Coronary Heart Disease in Women
Rich-Edwards, J. W., Manson, J. E., Hennekens, C. H., & Buring, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322607 · Cited by 383
Physical health of people with severe mental illness
Phelan, M., Stradins, L., & Morrison, S. (2001) · British medical journal · doi:10.1136/bmj.322.7284.443 · Cited by 376
Quality of Preventive Medical Care for Patients With Mental Disorders
Druss, B. G., Rosenheck, R. A., Desai, M. M., & Perlin, J. B. (2002) · Medical Care · doi:10.1097/00005650-200202000-00007 · Cited by 376
Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
Hert, M. A. F. D., Dobbelaere, M., Sheridan, E. M., Cohen, D., & Correll, C. U. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.09.011 · Cited by 365
Self-citation
The Health and Recovery Peer (HARP) Program: A peer-led intervention to improve medical self-management for persons with serious mental illness
Druss, B. G., Zhao, L., von Esenwein, S. A., Bona, J. R., Fricks, L., Jenkins-Tucker, S., Sterling, E., DiClemente, R., & Lorig, K. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.01.026 · Cited by 363
2007 ESH‐ESC Guidelines for the management of arterial hypertension
Mansia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Blood Pressure · doi:10.1080/08037050701461084 · Cited by 361
Smoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus
Yeh, H. C., Duncan, B. B., Schmidt, M. I., Wang, N.-Y., & Brancati, F. L. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-1-201001050-00005 · Cited by 360
Nicotine Transdermal Patch and Atypical Antipsychotic Medications for Smoking Cessation in Schizophrenia
George, T. P., Ziedonis, D. M., Feingold, A., Pepper, W. T., Satterburg, C. A., Winkel, J. D., Rounsaville, B. J., & Kosten, T. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1835 · Cited by 354
Disparities in Diabetes Care: Impact of Mental Illness
Frayne, S. M., Halanych, J. H., Miller, D. R., Wang, F., Lin, H., Pogach, L., Sharkansky, E. J., Keane, T. M., Skinner, K. M., Rosen, C. S., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2631 · Cited by 336
Comorbid Somatic Illnesses in Patients With Severe Mental Disorders: Clinical, Policy, and Research Challenges
Fleishhacker, W. W., Cetkovich-Bakmas, M., De Hert, M., Hennekens, C. H., Lambert, M., Leucht, S., Maj, M., McIntyre, R. S., Naber, D., Newcomer, J. W., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0401 · Cited by 328 · cited 3×
“), the majority of actions should be adapted to the local needs and circumstances (7).”
BackgroundSelf-citation
Comorbidity of Medical Illnesses Among Adults With Serious Mental Illness Who Are Receiving Community Psychiatric Services
Sokal, J., Messias, E., Dickerson, F. B., Kreyenbuhl, J., Brown, C. H., Goldberg, R. W., & Dixon, L. B. (2004) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000130135.78017.96 · Cited by 320
Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials
Álvarez‐Jiménez, M., Hetrick, S. E., González‐Blanch, C., Gleeson, J., & McGorry, P. D. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.042853 · Cited by 315
Insulin Sensitivity, Insulin Secretion, and Abdominal Fat
Wagenknecht, L. E., Langefeld, C. D., Scherzinger, A. L., Norris, J. M., Haffner, S. M., Saad, M. F., & Bergman, R. N. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2490 · Cited by 302
A placebo controlled trial of bupropion for smoking cessation in schizophrenia
George, T. P., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J., & Kosten, T. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01339-2 · Cited by 291
WPA guidance on steps, obstacles and mistakes to avoid in the implementation of community mental health care
Thornicroft, G., Alem, A., dos Santos, R. A., Barley, E. A., Drake, R. E., Gregório, G., Hanlon, C., Ito, H., Latimer, E. A., LAW, A., et al. (2010) · World Psychiatry · doi:10.1002/j.2051-5545.2010.tb00276.x · Cited by 289
Increasing Burden of Cardiovascular Disease
Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.11.1095 · Cited by 289
Sexual dysfunction in depression and anxiety: Conceptualizing sexual dysfunction as part of an internalizing dimension
Laurent, S. M., & Simons, A. D. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.06.007 · Cited by 288
From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
Correll, C. U. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71701-6 · Cited by 277
Self-citation
Medical comorbidity in schizophrenia
Lambert, T. J. R., Velakoulis, D., & Pantelis, C. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05311.x · Cited by 252
Medication-Induced Hyperprolactinemia
Molitch, M. E. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.8.1050 · Cited by 251
Validation of a physical activity assessment tool for individuals with schizophrenia
Faulkner, G., Cohn, T. A., & Remington, G. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.020 · Cited by 251
From Silos To Bridges: Meeting The General Health Care Needs Of Adults With Severe Mental Illnesses
Horvitz-Lennon, M. V., Kilbourne, A. M., & Pincus, H. A. (2006) · Health Affairs · doi:10.1377/hlthaff.25.3.659 · Cited by 250
Smoking cessation in severe mental illness: what works?
Banham, L., & Gilbody, S. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02946.x · Cited by 243
Use of waist circumference to predict insulin resistance: retrospective study
Wahrenberg, H., Hertel, K., Leijonhufvud, B.-M., Persson, L., Toft, E., & Arner, P. (2005) · BMJ · doi:10.1136/bmj.38429.473310.ae · Cited by 242
Medical illness in patients with schizophrenia.
Goldman, L. S. (1999) · PubMed · Cited by 236
Smoking Cessation Treatment for Patients With Schizophrenia
Addington, J., el‐Guebaly, N., Campbell, W., Hodgins, D. C., & Addington, D. E. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.974 · Cited by 229
Interventions to reduce weight gain in schizophrenia
Faulkner, G., Cohn, T. A., & Remington, G. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005148.pub2 · Cited by 226
Adjunctive Treatment With a Dopamine Partial Agonist, Aripiprazole, for Antipsychotic-Induced Hyperprolactinemia: A Placebo-Controlled Trial
Shim, J.-C., Shin, J.-G. K., Kelly, D. L., Jung, D.-U., Seo, Y.-S., Liu, K., Shon, J., & Conley, R. R. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06071075 · Cited by 212
The effects of undertreated chronic medical illnesses in patients with severe mental disorders.
Fagiolini, A., & Goracci, A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.7075su1c.04 · Cited by 205
Managing Atypical Antipsychotic–Associated Weight Gain
Menza, M. A., Vreeland, B., Minsky, S. K., Gara, M. A., Radler, D. R., & Sakowitz, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0404 · Cited by 201
Use of General Medical Services by VA Patients With Psychiatric Disorders
Cradock-O'Leary, J., Young, A. S., Yano, E. M., Wang, M., & Lee, M. L. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.7.874 · Cited by 197
Sexual dysfunction in schizophrenia: focus on recent evidence
Baggaley, M. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.924 · Cited by 191
Access to Medical Care Among Persons With Psychotic and Major Affective Disorders
Bradford, D. W., Kim, M., Braxton, L. E., Marx, C. E., Butterfield, M. I., & Elbogen, E. B. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.8.847 · Cited by 188
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
Bobes, J., Arango, C., Garcia-Garcia, M., & Rejas, J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1030 · Cited by 181
Self-citation
Health habits of patients with schizophrenia
Roick, C., Fritz-Wieacker, A., Matschinger, H., Heider, D., Schindler, J., Riedel-Heller, S. G., & Angermeyer, M. C. (2007) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-007-0164-5 · Cited by 180
Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents
Haupt, D. W., Rosenblatt, L. C., Kim, E., Baker, R. A., Whitehead, R. E., & Newcomer, J. W. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030383 · Cited by 180
Self-citation
Cardiac side effects of psychiatric drugs
Mackin, P. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.915 · Cited by 176
Metabolic Monitoring for Patients Treated with Antipsychotic Medications
Cohn, T. A., & Sernyak, M. J. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100804 · Cited by 176
World Health Organization's Mental Health Atlas 2005:implications for policy development.
Saxena, S., Sharan, P., Garrido‐Cumbrera, M., & Saraceno, B. (2006) · PubMed · Cited by 172
Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia
Barnett, A. H., Mackin, P., Chaudhry, I. B., Farooqi, A., Gadsby, R., Heald, A. H., Hill, J., Millar, H. L., Peveler, R., Rees, A., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107075509 · Cited by 168
Use and Safety of Antipsychotic Drugs During Pregnancy
Einarson, A., & Boskovic, R. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000351878.45260.94 · Cited by 167
A Program for Managing Weight Gain Associated With Atypical Antipsychotics
Vreeland, B., Minsky, S. K., Menza, M. A., Radler, D. R., Roemheld‐Hamm, B., & Stern, R. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.8.1155 · Cited by 160
Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia.
Hennekens, C. H. (2007) · PubMed · Cited by 150
Cardiovascular and Respiratory Risk Factors and Symptoms among General Practice Patients with Long-Term Mental Illness
Kendrick, T. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.6.733 · Cited by 145
A UK Audit of Screening for the Metabolic Side Effects of Antipsychotics in Community Patients
Barnes, T. R. E., Paton, C., Cavanagh, M.-R., Hancock, E., Taylor, D. M., & Health, O. B. O. T. U. P. O. F. M. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm038 · Cited by 145
The Atypical Antipsychotic Therapy and Metabolic Issues National Survey
Newcomer, J. W., Nasrallah, H. A., & Loebel, A. D. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000142281.85207.d5 · Cited by 133
Self-citation
Management of antipsychotic-related weight gain
Maayan, L. A., & Correll, C. U. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.85 · Cited by 132
Self-citation
Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics
Hasnain, M., Fredrickson, S. K., Vieweg, W. V. R., & Pandurangi, A. K. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0112-8 · Cited by 121
Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs
Paton, C., Esop, R., Young, C., & Taylor, D. M. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00372.x · Cited by 118
From Galactorrhea to Osteopenia: Rethinking Serotonin–Prolactin Interactions
Emiliano, A. B., & Fudge, J. L. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300412 · Cited by 111
Bridging the gap between mental and physical health: a multidisciplinary approach.
Vreeland, B. (2007) · PubMed · Cited by 111
Élaboration de recommandations pour le suivi somatique des patients atteints de pathologie mentale sévère
Saravane, D., Fève, B., Francès, Y., Corruble, E., Lançon, C., Chanson, P., Maison, P., Terra, J.-L., & Azorin, J. (2009) · L Encéphale · doi:10.1016/j.encep.2008.10.014 · Cited by 105
Effects of Sustained-Release Bupropion and Supportive Group Therapy on Cigarette Consumption in Patients With Schizophrenia
Weiner, E., Ball, M. P., Summerfelt, A. T., Gold, J. M., & Buchanan, R. W. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.635 · Cited by 103
Do guidelines for severe mental illness promote physical health and well-being?
Citrome, L., & Yeomans, D. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059505 · Cited by 103
Schizophrenia: who is at risk? Who is a case?
Verdoux, H., & Cougnard‐Grégoire, A. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000201496.23259.85 · Cited by 102
Clinicians' recognition of the metabolic adverse effects of antipsychotic medications
Buckley, P. F., Miller, D. D., SINGER, B., ARENA, J., & Stirewalt, E. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.04.010 · Cited by 102
A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients
Mackin, P., Bishop, D. R., & Watkinson, H. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-28 · Cited by 96
Antipsychotics and hyperprolactinaemia: Clinical recommendations
Peveler, R., Branford, D. M. L., Citrome, L., Fitzgerald, P., Harvey, P. W., Holt, R. I. G., Howard, L. M., Kohen, D., Jones, I. R., O’Keane, V., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107087346 · Cited by 93
Physical health care in persons with severe mental illness: a public health and ethical priority
Maj, M. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00196.x · Cited by 92
Screening for Diabetes and Other Metabolic Abnormalities in Patients With Schizophrenia and Schizoaffective Disorder
van Winkel, R., Binder, M. D., Eyck, D. V., Hanssens, L., Hanssens, L., Wampers, M., Scheen, A. J., & Peuskens, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1002 · Cited by 92
Interventions to Reduce Weight Gain in Schizophrenia
Faulkner, G., Cohn, T., & Remington, G. J. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm022 · Cited by 92
Cost-Effective Screening for the Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotic Medications
Straker, D., Correll, C. U., Kramer‐Ginsberg, E., Abdulhamid, N., Koshy, F., Rubens, E. O., Saint-Vil, R., Kane, J. M., & Manu, P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1217 · Cited by 89
Self-citation
Physical Health of the Long-Term Mentally Ill in the Community
Brugha, T. S., Wing, J., & Smith, B. L. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.155.6.777 · Cited by 86
Effects of Service Barriers on Health Status of Older Chinese Immigrants in Canada
Lai, D. W. L., & Chau, S. (2007) · Social Work · doi:10.1093/sw/52.3.261 · Cited by 83
Belgian consensus on metabolic problems associated with atypical antipsychotics
Nayer, A. D., Hert, M. D., Scheen, A. J., Gaal, L. V., Peuskens, J., & on behalf of the Consensus Group (2005) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500510018310 · Cited by 80
Series Introduction and Cardiovascular Disease in Patients With Schizophrenia
Hennekens, C. H., & Newcomer, J. W. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0507e12 · Cited by 78
Self-citation
[Consensus on physical health of patients with schizophrenia from the Spanish Societies of Psychiatry and Biological Psychiatry].
Ruiz, J. S., García, J. B., Ruiloba, J. V., Ubago, J. G., & González, M. P. G.-P. (2008) · Actas Españolas de Psiquiatría · Cited by 74
International strategies to address obesity
Hill, J. O., Peters, J. C., Catenacci, V. A., & Wyatt, H. R. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00437.x · Cited by 74
Determinants of Poor Dental Care in Patients With Schizophrenia
Nielsen, J., Munk‐Jørgensen, P., Skadhede, S., & Correll, C. U. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05318yel · Cited by 68
Self-citation
Cardiometabolic effects of physical activity interventions for people with schizophrenia
Vancampfort, D., Knapen, J., Binder, M. D., van Winkel, R., Deckx, S., Maurissen, K., Peuskens, J., Simons, J., & Probst, M. (2009) · Physical Therapy Reviews · doi:10.1179/108331909x12540993898053 · Cited by 61
Physical health management in psychiatric settings
Hert, M. A. F. D., van Winkel, R., Silić, A., Eyck, D. V., & Peuskens, J. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71702-8 · Cited by 58
Efficacy of behavioural interventions in managing atypical antipsychotic weight gain
Gabriele, J. M., Dubbert, P. M., & Reeves, R. R. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00570.x · Cited by 58
Use of Antipsychotics in the Management of Schizophrenia during Pregnancy
Trixler, M., G??ti, ?., Fekete, S., & T??nyi, T. (2005) · Drugs · doi:10.2165/00003495-200565090-00002 · Cited by 56
Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm
Waterreus, A. J., & Laugharne, J. D. E. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02344.x · Cited by 53
Short Communication
Stokes, C. S., & Peet, M. (2004) · Nutritional Neuroscience · doi:10.1080/10284150400010012 · Cited by 52
Item-of-service payments for general practitioner care of severely mentally ill persons: does the money matter?
Burns, T., & Cohen, A. (1998) · Europe PMC (PubMed Central) · Cited by 50
A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine
Cormac, I., Brown, A. R. H., Creasey, S., Ferriter, M., & Huckstep, B. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01482.x · Cited by 50
Point-of-care blood ketone testing: screening for diabetic ketoacidosis at the emergency department.
Charles, R. A., Bee, Y. M., Eng, P., & Goh, S. (2007) · PubMed · Cited by 49
Impact of substance use on the physical health of patients with bipolar disorder
García‐Portilla, M. P., Sáiz, P. A., Benabarre, A., Flórez, G., Bobes-Bascarán, T., Díaz, E. M. F., Bousoño, M., & Bobes, J. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01498.x · Cited by 48
Self-citation
Mental Health
Bank, W. (2003) · doi:10.1596/9719 · Cited by 48
Implementation of monitoring and management guidelines for second-generation antipsychotics.
Sernyak, M. J. (2007) · PubMed · Cited by 46
Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics
Bushe, C., Yeomans, D., Floyd, T., & Smith, S. M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088436 · Cited by 45
Management of physical health in patients with schizophrenia: practical recommendations
Heald, A. H., Montejo, A. L., Millar, H. L., Hert, M. A. F. D., McCrae, J., & Correll, C. U. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71706-5 · Cited by 41
Self-citation
An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder
Hirschfeld, R. M. A., Eerdekens, M., Kalali, A. H., Canuso, C. M., Khan, A. A., Karcher, K., & Palumbo, J. (2005) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000177017.41558.fc · Cited by 40
Management of Atypical Antipsychotic Drug‐Induced Weight Gain: Focus on Metformin
Miller, L. J. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.725 · Cited by 37
Clinical questions and uncertainty — prolactin measurement in patients with schizophrenia and bipolar disorder
Walters, J., & Jones, I. D. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107086516 · Cited by 37
Management of physical health in schizophrenia: A stepping stone to treatment success
Millar, H. L. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.02.002 · Cited by 37
Physical illness and psychiatric disorders
Ananth, J. (1984) · Comprehensive Psychiatry · doi:10.1016/0010-440x(84)90040-3 · Cited by 34
[Prevention and treatment of somatic complications arising from the use of antipsychotics].
Cahn, W., Ramlal, D., Bruggeman, R., de Haan, L., Scheepers, F. E., van Soest, M. M., Assies, J., & Slooff, C. J. (2008) · PubMed · Cited by 32
Implications for policy development
Brown, H. (2008) · Cited by 29
Effects of Adopting a Smoke-Free Policy in State Psychiatric Hospitals
Hollen, V., Ortiz, G., Schacht, L. M., Mojarrad, M. G., Lane, G. M., & Parks, J. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.9.899 · Cited by 27
Oral health‐related quality of life and dental status in an outpatient psychiatric population: A multivariate approach
Persson, K., Axtelius, B., Söderfeldt, B., & Östman, M. (2010) · International Journal of Mental Health Nursing · doi:10.1111/j.1447-0349.2009.00639.x · Cited by 26
Treatment decisions in major mental illness: weighing the outcomes.
Vreeland, B. (2007) · PubMed · Cited by 25
Diabetic Ketoacidosis
Wilson, J. F. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-1-201001050-01001 · Cited by 25
Exercise, Insulin Resistance, and Hypertension: A Complex Relationship
Brock, C. M., King, D. S., Wofford, M. R., & Harrell, T. K. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.60 · Cited by 24
The effectiveness of differing dental health education programmes in improving the oral health of adults with mental handicaps attending Birmingham adult training centres.
Shaw, M. J., & Shaw, L. (1991) · PubMed · Cited by 24
Change in psychiatrists’ attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the consensus on physical health in patients with schizophrenia
Bobes, J., Alegría, A. A., Sáiz-González, M. D., Barber, I., Pérez, J. L., & Sáiz‐Ruiz, J. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2010.04.004 · Cited by 22
Self-citation
Physical health of patients in rehabilitation and recovery: a survey of case note records
Greening, J. (2005) · Psychiatric Bulletin · doi:10.1192/pb.29.6.210 · Cited by 19
Development of a Health Screening Clinic
Millar, H. L. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71703-x · Cited by 18
Diabetic ketoacidosis and hyperglycaemic hyperosmolar syndrome – clinical guidelines
de Beer, K., Michael, S., Thacker, M., Wynne, E., Pattni, C., Gomm, M., Ball, C., Walsh, D., Thomlinson, A., & Ullah, K. (2008) · Nursing in Critical Care · doi:10.1111/j.1478-5153.2007.00259.x · Cited by 18
Creating a Health Care Team to Manage Chronic Medical Illnesses in Patients With Severe Mental Illness
Kane, J. M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.7075su1c.06 · Cited by 17
Inequalities in health care provision for people with severe mental illness
Lawrence, D. M., Kisely, S., & Phd, M. (2010) · Cited by 17
Mistakes to avoid in the implementation of community mental health care
Maj, M. (2010) · World Psychiatry · doi:10.1002/j.2051-5545.2010.tb00275.x · Cited by 16
A Clinical Monitoring System for Clozapine
Castle, D. J., Lambert, T. J. R., Melbourne, S., Cox, A., Boardman, G., Fairest, K., Davy, M., Goh, J., Kuluris, B., & Berk, M. (2006) · Australasian Psychiatry · doi:10.1080/j.1440-1665.2006.02267.x · Cited by 15
Relation of Impaired Fasting and Postload Glucose With Incident Type 2 Diabetes in a Dutch Population: The Hoorn Study
de Vegt, F., Dekker, J. M., Jager, A., Hienkens, E., Kostense, P. J., Stehouwer, C. D. A., Nijpels, G., Bouter, L. M., & Heine, R. J. (2001) · JAMA · doi:10.1001/jama.285.16.2109 · Cited by 10
Connecting patient needs with treatment management
Kerwin, R. W. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01312.x · Cited by 10
Datapoints: Self-Reported Access to General Medical and Psychiatric Care Among Veterans With Bipolar Disorder
Zeber, J. E., McCarthy, J. F., Bauer, M. S., & Kilbourne, A. M. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.6.740 · Cited by 7
Is Second-Generation Antipsychotic–Induced Hyperprolactinemia Due to Biologically Active Prolactin or to Biologically Inactive Macroprolactin?
Tschoner, A., Engl, J., Rettenbacher, M. A., Kaser, S., Ott, H. W., Fleischhacker, W. W., Patsch, J. R., & Ebenbichler, C. F. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08l04509 · Cited by 7
Patients must be able to derive maximum benefit from a psychiatrist's medical skills and broad training
Craddock, N. J., & Craddock, B. (2010) · World Psychiatry · doi:10.1002/j.2051-5545.2010.tb00259.x · Cited by 6
Small Changes: A Big Idea for Addressing Obesity
Hill, J. O., & Wyatt, H. R. (2006) · Obesity Management · doi:10.1089/obe.2006.2.227 · Cited by 6
A clinical monitoring system for clozapine
Castle, D. J., Lambert, T. J. R., Melbourne, S., et al. (2006) · Australasian Psychiatry · doi:10.1111/j.1440-1665.2006.02267.x · Cited by 5
Usefulness of glycosylated haemoglobin (HbA1c) to screen for diabetes in patients with schizophrenia
Hanssens, L. S., DEHERT, M., VANEYCK, D., Wampers, M., Scheen, A. J., & Peuskens, J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.03.038 · Cited by 4
Self-citation
Diabetic ketoacidosis guidelines and protection from aspiration pneumonitis
Silversides, J. A., & Farling, P. A. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02771.x · Cited by 3
Bridging a cultural divide within medicine: a role for psychiatrists?
Hollins, S. C. (2010) · World Psychiatry · doi:10.1002/j.2051-5545.2010.tb00261.x · Cited by 1

Research works printed but not linked: 6

Parks J, 2006, Morbidity and mortality in people with serious mental illness
World Health Organization., 2005, Mental Health Atlas, revised version
10.1176/appi.ps.58.6.740 · DOI
Parks J, 2008, Obesity reduction and prevention strategies for individuals with serious mental illness
10.1176/appi.ajp.161.8.1334 · DOI
Cormac I, 2009, Physical heath in mental health. Final report of a scoping group, 62

Sorted by citations

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: A large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., et al. (2017) · World Psychiatry · doi:10.1002/wps.20420 · Cited by 1,729
Self-citation
The future of mental health care: peer-to-peer support and social media
Naslund, J. A., Aschbrenner, K. A., Marsch, L. A., & Bartels, S. J. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015001067 · Cited by 1,180
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & Binder, M. D. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr148 · Cited by 1,124
Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas
Liu, N. H., Daumit, G. L., Dua, T., Aquila, R., Charlson, F., Cuijpers, P., Druss, B., Dudek, K., Freeman, M., Fujii, C., et al. (2017) · World Psychiatry · doi:10.1002/wps.20384 · Cited by 865
Three Approaches to Understanding and Classifying Mental Disorder: ICD-11, DSM-5 , and the National Institute of Mental Health’s Research Domain Criteria (RDoC)
Clark, L. A., Cuthbert, B., Lewis-Fernández, R., Narrow, W. E., & Reed, G. M. (2017) · Psychological Science in the Public Interest · doi:10.1177/1529100617727266 · Cited by 688

See all 870

Authors: DE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., GAUTAM, S., DETRAUX, J., & CORRELL, C. U.
Affiliations: University of Groningen (NL)
Universidad de Oviedo (ES)
Technical University of Munich (DE)
University of Nairobi (KE)
Washington University in St. Louis (US)
Nnamdi Azikiwe University (NG)
SMS Medical College (IN)
KU Leuven (BE)
Albert Einstein College of Medicine (US)
ORCID: COHEN, DAN
BOBES, JULIO
LEUCHT, STEFAN
NDETEI, DAVID M.
NEWCOMER, JOHN W.
UWAKWE, RICHARD
DETRAUX, JOHAN
CORRELL, CHRISTOPH U.
Venue: World Psychiatry
Publisher: Wiley
Published: 2011-06
Volume: 10
Issue: 2
Pages: 138-151
ISSN: 1723-8617 (ISSN-L)
2051-5545
DOI: 10.1002/j.2051-5545.2011.tb00036.x
PMC: PMC3104888
OpenAlex: W1828019950
Cited by: 870
References: 150
Citations by year: 2026: 39 · 2025: 50 · 2024: 50 · 2023: 57 · 2022: 68 · 2021: 54 · 2020: 72 · 2019: 76 · 2018: 68 · 2017: 56 · 2016: 79 · 2015: 57 · 2014: 37 · 2013: 57 · 2012: 39
FWCI: 31.70
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 650 d)
Locations: World Psychiatry (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Lirias (submittedVersion)
mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Funders: Bristol-Myers Squibb
Pfizer
Società Italiana di Psichiatria Biologica
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
Keywords: physical illness, severe mental illness, barriers to care, physical health screening, treatment guidelines, lifestyle risk factors, smoking, diet, physical activity, developing countries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks